¥4,356.00
0.11% yesterday
Tokyo, Oct 08, 08:30 am CET
ISIN
JP3463000004
Symbol
4502
Index

Takeda Pharmaceutical Stock price

¥4,356.00
-294.00 6.32% 1M
+145.00 3.44% 6M
+175.00 4.19% YTD
+146.00 3.47% 1Y
+567.00 14.96% 3Y
+701.00 19.18% 5Y
-1,067.00 19.68% 10Y
-2,234.00 33.90% 20Y
Tokyo, Closing price Wed, Oct 08 2025
-5.00 0.11%
ISIN
JP3463000004
Symbol
4502
Index
Industry

Key metrics

Basic
Market capitalization
¥6.9t
Enterprise Value
¥11.0t
Net debt
¥4.1t
Cash
¥419.2b
Shares outstanding
1.6b
Valuation (TTM | estimate)
P/E
49.8 | 28.0
P/S
1.5 | 1.5
EV/Sales
2.5 | 2.4
EV/FCF
13.5
P/B
1.0
Dividends
DPS
¥200.00
Yield 1Y | 5Y
4.6% | 4.7%
Growth 1Y | 5Y
2.0% | 2.1%
Payout 1Y | 3Y
286.7% | 155.6%
Increased
3 Years
Financials (TTM | estimate)
Revenue
¥4.5t | ¥4.6t
EBITDA
¥972.9b | ¥1.2t
EBIT
¥418.6b | ¥402.0b
Net Income
¥136.9b | ¥243.1b
Free Cash Flow
¥817.9b
Growth (TTM | estimate)
Revenue
1.5% | 0.2%
EBITDA
2.3% | 13.1%
EBIT
1.0% | -25.2%
Net Income
-8.7% | 125.3%
Free Cash Flow
84.1%
Margin (TTM | estimate)
Gross
64.8%
EBITDA
21.7% | 27.1%
EBIT
9.3%
Net
3.1% | 5.3%
Free Cash Flow
18.3%
Financial Health
Equity Ratio
48.7%
Return on Equity
1.6%
ROCE
3.5%
ROIC
2.6%
Debt/Equity
0.7
More
EPS
¥87.5
FCF per Share
¥523.6
Short interest
-
Employees
49k
Rev per Employee
¥93.0m
Show more

Is Takeda Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,997 stocks worldwide.

Takeda Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Takeda Pharmaceutical forecast:

11x Buy
55%
9x Hold
45%

Analyst Opinions

20 Analysts have issued a Takeda Pharmaceutical forecast:

Buy
55%
Hold
45%

Financial data from Takeda Pharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
4,480,246 4,480,246
2% 2%
100%
- Direct Costs 1,577,938 1,577,938
6% 6%
35%
2,902,308 2,902,308
1% 1%
65%
- Selling and Administrative Expenses 1,090,621 1,090,621
1% 1%
24%
- Research and Development Expense 705,655 705,655
4% 4%
16%
972,862 972,862
2% 2%
22%
- Depreciation and Amortization 554,214 554,214
3% 3%
12%
EBIT (Operating Income) EBIT 418,648 418,648
1% 1%
9%
Net Profit 136,923 136,923
9% 9%
3%

In millions JPY.

Don't miss a Thing! We will send you all news about Takeda Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Head office Japan
CEO Christophe Weber
Employees 49,281
Founded 1781
Website www.takeda.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today